Growth Metrics

Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)

Insight Molecular Diagnostics' Equity Income history spans 2 years, with the latest figure at -$270000.0 for Q1 2021.

  • On a quarterly basis, Equity Income rose 17.93% to -$270000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was -$270000.0, a 82.55% increase, with the full-year FY2021 number at -$270000.0, up 82.55% from a year prior.
  • Equity Income hit -$270000.0 in Q1 2021 for Insight Molecular Diagnostics, up from -$435000.0 in the prior quarter.
  • Over the last five years, Equity Income for IMDX hit a ceiling of -$270000.0 in Q1 2021 and a floor of -$482000.0 in Q3 2020.